Chronic Pain

Utilizing CIH treatment is effective on its own or in combination with opioid treatment for lower costs.

Study shows single-session pain relief class noninferior to 8-session cognitive behavioral therapy for pain catastrophizing, pain intensity, and pain interference.

In part 2 of an interview with HCPLive, Dr. Saxe focuses on the role of microbiota in pain and how concomitant conditions in patients are often nutritionally linked.

Dr. Saxe discusses the role of nutrition in determining levels of inflammation and its potential in treating patients.

Dr. Marienfield discusses stigma as a major barrier in addiction treatment, as well as determining success based on patient goal.

Dr. Marienfield discusses therapy options for substance abuse patients in recovery.

Opioids are likely still needed in most cases following trauma or surgery.

Data show patients expected moderate improvements across all PCOQ domains with a median improvement range of 45% - 53.7%.

Dr. Moeller-Bertram will co-chair a live conference focusing on the different aspects of treating pain.

Data show 82% of studies reported significant abstinence from psychomotor stimulant use at the end-of-treatment assessment.

Data show prevalence of pain increased with age in all age groups, while it was lower among men and non-Hispanic Asian adults.

Data show skeletal muscle relaxant associated with increased risk of fall-related injury (OR 1.28) and all-cause hospitalization (OR 1.11).

Black patients received different opioid prescriptions compared to White patients, even after clinicians were given additional patient-level data.

A new study finds a 2-step chronic pain screening process helped identify patients in primary care with previously undocumented chronic pain.

Data show total amount of patients pre-guideline was 558,175 compared to 532,962 patients after the release of the guideline.

Physicians who performed well on ABIM examination less likely to prescribe opioids for back pain compared to physicians who did not perform well.

Opioid prescription decreased substantially in 2 years following 2016 CDC guideline for prescribing opioids for chronic pain.

A daily opioid dose higher than 90 MME is associated with 3-fold risk increase, compared to 90 MME or lower.

Data show sublingual sufentanil tablets did not affect pain scores, but did benefit patient satisfaction outcomes.

New research over 2 decades shows patients with opioid use disorder are often prescribed opioid analgesic prior to OUD diagnosis, although rates have decreased in recent years.

Management of the painkiller addiction crisis looked optimistic headed into 2020. The pandemic brought a heavy toll to efforts that took years to establish.

Telemedicine visits for opioid use disorder increased from 0.48% in week 1 to 23.53% in week 13 in 2020.

Dr. Tobias Moeller-Bertram discusses how alternative therapies could replace opioids in the future for chronic pain.

An interview with a pain specialist on advancing alternative pain therapy options.

Adamis plans to address agency concerns regarding the naloxone injection application.

The new drug allows for flexible dosing so as to address individual patient needs.

The indication limits the new opioid to clinical setting use—no take-home prescriptions.

Manipulative techniques are not effective for chronic low back pain among relatively young individuals.

The Patient Controller will join a growing list of Abbott digital care products aimed at streamlining the therapeutic experience.

The findings suggest cannabis should be further investigated as an alternative to opioids.